These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 19615253

  • 21. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells].
    Zhang J, Bai HJ.
    Zhonghua Zhong Liu Za Zhi; 2021 Oct 23; 43(10):1062-1068. PubMed ID: 34695896
    [Abstract] [Full Text] [Related]

  • 22. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.
    Ju X, Yu H, Liang D, Jiang T, Liu Y, Chen L, Dong Q, Liu X.
    Biomed Pharmacother; 2018 Jun 23; 102():549-554. PubMed ID: 29597088
    [Abstract] [Full Text] [Related]

  • 23. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X, Wang S, Zhou J, Xing H, Xu G, Wang B, Chen G, Lu YP, Ma D.
    Oncol Rep; 2005 Jul 23; 14(1):275-9. PubMed ID: 15944801
    [Abstract] [Full Text] [Related]

  • 24. [Effects of hyperthermia combined platinum-based drugs on ovarian cancer cell lines SKOV3].
    Xie D, Yin RT, Li KM, Xiao P, Tong LX.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul 23; 45(4):606-11. PubMed ID: 25286685
    [Abstract] [Full Text] [Related]

  • 25. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W, Liang B, Yin J, Li X, Cheng J.
    Cell Biochem Biophys; 2015 May 23; 72(1):203-13. PubMed ID: 25510462
    [Abstract] [Full Text] [Related]

  • 26. Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells.
    Wang Z, Xie Y, Wang H.
    Cancer Biol Ther; 2005 Jul 23; 4(7):716-9. PubMed ID: 15970709
    [Abstract] [Full Text] [Related]

  • 27. [Suppression of ATR reverses the cisplatin resistance in ovarian cancer SKOV3 cells].
    Yang Z, Sun C, Liu Y, Gong C, Chen G, Weng D.
    Zhonghua Zhong Liu Za Zhi; 2014 Nov 23; 36(11):805-10. PubMed ID: 25620475
    [Abstract] [Full Text] [Related]

  • 28. Construction of survivin siRNA expression vector and its regulation on cell cycle and proliferation in MCF-7 cells.
    Li LP, Liang NC, Luo CQ.
    Ai Zheng; 2004 Jul 23; 23(7):742-8. PubMed ID: 15248905
    [Abstract] [Full Text] [Related]

  • 29. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
    Li Z, Wang Q, Zhang W, Yang Z, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov 23; 50(11):854-60. PubMed ID: 26887775
    [Abstract] [Full Text] [Related]

  • 30. Effect of shRNA targeting survivin on ovarian cancer.
    Xing J, Jia CR, Wang Y, Guo J, Cai Y.
    J Cancer Res Clin Oncol; 2012 Jul 23; 138(7):1221-9. PubMed ID: 22426961
    [Abstract] [Full Text] [Related]

  • 31. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ, Sun ZL, Wu WG, Xing J, He YF, Xin DM, Han P.
    Genet Mol Res; 2015 Mar 30; 14(1):2450-60. PubMed ID: 25867391
    [Abstract] [Full Text] [Related]

  • 32. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ, Chen BL, Xin XY.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct 30; 146(2):222-6. PubMed ID: 19758744
    [Abstract] [Full Text] [Related]

  • 33. [Experimental therapy of survivin antisense oligonucleotide for human ovarian cancer cell SKOV3].
    Wei SQ, Bi S, Zheng JH, Zhang GM, Sui LH, Pan SH.
    Ai Zheng; 2004 Aug 30; 23(8):890-5. PubMed ID: 15301709
    [Abstract] [Full Text] [Related]

  • 34. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor.
    Wen L, Hong D, Yanyin W, Mingyue Z, Baohua L.
    Arch Gynecol Obstet; 2013 May 30; 287(5):997-1004. PubMed ID: 23212665
    [Abstract] [Full Text] [Related]

  • 35. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y, Zhang L, Wu HJ, Liu WX, Hao Q.
    Zhonghua Zhong Liu Za Zhi; 2011 May 30; 33(5):324-30. PubMed ID: 21875458
    [Abstract] [Full Text] [Related]

  • 36. [Expression of microRNA-100 and its correlation with drug resistance in human ovarian cancer SKOV3/DDP cells].
    Guo P, Peng D, Xiong X, Zhang S.
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov 30; 35(11):1624-7. PubMed ID: 26607088
    [Abstract] [Full Text] [Related]

  • 37. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY, Li N, Cui YL.
    Cancer Res Treat; 2020 Jul 30; 52(3):798-814. PubMed ID: 32124583
    [Abstract] [Full Text] [Related]

  • 38. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S, Tan W, Du B, Liu W, Li W, Che D, Zhang G.
    Mol Med Rep; 2016 Apr 30; 13(4):3342-8. PubMed ID: 26935490
    [Abstract] [Full Text] [Related]

  • 39. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.
    Liu YK, Jia YJ, Liu SH, Ma J.
    Cancer Chemother Pharmacol; 2021 Mar 30; 87(3):405-414. PubMed ID: 33392640
    [Abstract] [Full Text] [Related]

  • 40. [Effects of recombinant human interleukin-24 alone and in combination with cisplatin on the growth of ovarian cancer cells in vitro].
    Wang S, Guo J, Tang Y, Zheng R, Song M, Sun W.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan 30; 30(1):33-6. PubMed ID: 24405596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.